NCT05307289View on ClinicalTrials.gov

Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma

NARecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

May 25, 2022

Primary Completion Date

May 25, 2028

Study Completion Date

October 25, 2028

Conditions

Melanoma (Skin)

Interventions

OTHER

Biposy

Biopsy at inclusion visit and at disease progression if applicable

Trial Locations (1)

06001

RECRUITING

CHU de Nice, Nice

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nice

OTHER